FdaApplication

BLA 125363

Back to search

Identifiers

Properties

PropertyValue
applicant_nameGlaxoSmithKline Biologicals
application_typeBLA
approval_date2012-06-14

Products (1)

ProductActive ingredientStrengthDosage form
MENHIBRIX—0.5MLInjection

1 product